Skip to main content

Stifel cuts cannabis industry view as analysts weigh Tilray

Stifel reduces 2022 U.S. cannabis sales view by $1.4 billion and cuts earnings targets on Scotts Miracle-Gro and Hydrofarm; Tilray in spotlight.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.